Literature DB >> 23228433

Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan.

A-H Hsu1, J-J Lee, C-Y Chiang, Y-H Li, L-K Chen, C-B Lin.   

Abstract

We assessed the association between diabetes mellitus and drug-resistant tuberculosis (TB). Among new patients, diabetes was significantly associated with any resistance to isoniazid excluding multidrug-resistant TB (MDR-TB; adjusted OR [aOR] 1.88, 95%CI 1.07-3.31), but not with MDR-TB (aOR 0.95, 95%CI 0.34-2.68). Among previously treated patients, diabetes was also significantly associated with INH resistance (aOR 6.76, 95%CI 1.53-29.98) but not with MDR-TB (aOR 1.52, 95%CI 0.59-3.95). We concluded that diabetes was associated with INH resistance and speculated that the sample size of retreatment cases was insufficient to confirm the association between diabetes and MDR-TB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228433     DOI: 10.5588/ijtld.11.0670

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  11 in total

Review 1.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

2.  Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection.

Authors:  J Daniel Kelly; Shou-Yean Grace Lin; Pennan M Barry; Chris Keh; Julie Higashi; John Z Metcalfe
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

Review 3.  Global and Regional Burden of Isoniazid-Resistant Tuberculosis.

Authors:  Courtney M Yuen; Helen E Jenkins; Carly A Rodriguez; Salmaan Keshavjee; Mercedes C Becerra
Journal:  Pediatrics       Date:  2015-06-01       Impact factor: 7.124

4.  The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis.

Authors:  Chen Yuan Chiang; Kuan Jen Bai; Hsien Ho Lin; Shun Tien Chien; Jen Jyh Lee; Donald A Enarson; Ting-I Lee; Ming-Chih Yu
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

5.  Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China.

Authors:  Fengling Mi; Guanglu Jiang; Jian Du; Liang Li; Wentao Yue; Anthony D Harries; Sven Gudmund Hinderaker; Yan Lin
Journal:  Glob Health Action       Date:  2014-05-19       Impact factor: 2.640

6.  Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis.

Authors:  Argita D Salindri; Maia Kipiani; Russell R Kempker; Neel R Gandhi; Lasha Darchia; Nestani Tukvadze; Henry M Blumberg; Matthew J Magee
Journal:  Open Forum Infect Dis       Date:  2016-06-16       Impact factor: 3.835

Review 7.  Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.

Authors:  Minhui Hu; Chunlan Zheng; Feng Gao
Journal:  Drug Des Devel Ther       Date:  2016-12-07       Impact factor: 4.162

8.  Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis.

Authors:  Qianqian Liu; Wenzhang Li; Miao Xue; Yunfeng Chen; Xinmiao Du; Chengdi Wang; Lina Han; Yin Tang; Yulin Feng; Chuanmin Tao; Jian-Qing He
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

9.  Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis.

Authors:  Balewgizie Sileshi Tegegne; Melkamu Merid Mengesha; Andreas A Teferra; Mamaru Ayenew Awoke; Tesfa Dejenie Habtewold
Journal:  Syst Rev       Date:  2018-10-15

10.  Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study.

Authors:  Nonhlanhla Christinah Dlamini; Dar-Der Ji; Li-Yin Chien
Journal:  BMC Infect Dis       Date:  2019-08-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.